Statistics

Total Visits

Views
A phase II trial of erlotinib as maintenance treatment after concurrent chemoradiotherapy in stage III non-small-cell lung cancer (NSCLC): a Galician Lung Cancer Group (GGCP) study98

Select a period of time:

Number of views in the range

Views
A phase II trial of erlotinib as maintenance treatment after concurrent chemoradiotherapy in stage III non-small-cell lung cancer (NSCLC): a Galician Lung Cancer Group (GGCP) study51

Views

Views
June 20254
July 20259
August 20251
September 202520
October 20254
November 202511
December 20252
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States23
Brazil20
Hong Kong3
United Kingdom2
Argentina1
Ecuador1
Morocco1
 

Top cities views

Views
Dallas16
Hong Kong3
São Paulo2
Alegrete1
Cachoeira do Sul1
Capivari1
Caseros1
Caxias1
Charlotte1
Duque de Caxias1